Bard to Sell Its Global Coronary Cath Lab Business to Arterial Vascular Engineering for $600 Million.

Business WireJuly 09, 1998

Linked as:

Extract


Bard to Sell Its Global Coronary Cath Lab Business to Arterial Vascular Engineering for $600 Million.

MURRAY HILL, N.J.--(BUSINESS WIRE)--July 9, 1998--C. R. Bard, Inc. (NYSE BCR) announced today that it has agreed to sell its global coronary cath lab business (angioplasty and angiography) to Ar...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company